Physician profile
Roy D Elterman
NPI 1215913751
$5,873,237.67
in general payments reported to CMS, 2019-2025
5 companies · $439K in 2025
The $439K reported for 2025 was more than what 99% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.4M · 2020: $1.1M · 2021: $1.0M · 2022: $889K · 2023: $631K · 2024: $342K · 2025: $439K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M · Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,411,643.00 |
| Food and Beverage | $204.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $5,872,979.36 | 2019-2025 | Sabril |
| Abbvie INC. | $204.48 | 2023-2025 | |
| Tris Pharma INC | $19.37 | 2019 | |
| Aquestive Therapeutics, INC. | $17.91 | 2019 | |
| Sunovion Pharmaceuticals INC. | $16.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Elterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.